Real-world effectiveness in the total population and in specific subgroups of treatment with palbociclib + endocrine therapy in HR+/HER2- Advanced Breast Cancer (ABC) patients: Interim Results of the PERFORM study 25. Oktober 2024 Korell M., Pfeiler G., Radosa J., Decker T., Deryal M., Fietz T., Köhler A., Schöttker B., Wilke J., Knoblich J., Petersen V., Dietrich M., Gabrysiak T., Breitbach A., Adams A., Seidel S., Glasstetter M., Serrer L., Lux M.P., Bartsch R., 2024 Download Centralized vs. decentralized testing for PD-L1 and HER2 in patients with metastatic gastric and esophageal cancer – Results from the German research platform SAPHIR Lordick, F., Bläker, H., Dechow, T., Binninger, A., Ringwald, K., de Buhr, R., von der Heyde, E., Zahn, M.-O., Nusch, A., Dörfel, S., Schulz, H.,… Weiterlesen Treatment reality and outcomes of patients with intermediate, locally advanced or metastatic hepatocellular cancer – Results from the prospective national intersectoral cohort study JADE Berg T, Dörfel S, Jordan F, Schultheiß M, Schröder J, Benkelmann R, Sergeev P, Heinzow H, Lamberti C, Weniger S, Siebenbach HU, Weinberg F, Jänicke… Weiterlesen